Center for Scientific Review Notice of Closed Meetings (April 2026)
AI-generated summary for informational purposes only. Not legal advice. See the original source for the authoritative text.
The National Institutes of Health (NIH) Center for Scientific Review has scheduled 13 closed virtual meetings between April 20 and April 24, 2026. These meetings are convened to review and evaluate grant applications for various research areas including mucosal immunology, health services research, respiratory topics, endocrinology, biomarkers, clinical data management, vascular and hematological systems, cardiovascular research, immunology training, NCI Research Specialist awards, ophthalmological therapies, clinical care interventions, and cancer health disparities. All meetings will be held virtually at the NIH Rockledge II facility in Bethesda, Maryland. The meetings are closed to the public under 5 U.S.C. 552b(c)(4) and (c)(6) to protect confidential trade secrets, commercial property, patentable material, and personal privacy of applicants.
AI-generated summary. May contain errors. Refer to official sources for legal decisions.
Key Changes
- 13 closed virtual grant review meetings scheduled for April 20-24, 2026
- Meetings closed to public under 5 U.S.C. 552b(c)(4) and 552b(c)(6)
- All meetings held at NIH Rockledge II, 6701 Rockledge Drive, Bethesda, MD 20892
+ 3 more changes with Pro
Obligations
What this law requires
Conduct 13 closed virtual meetings of the Center for Scientific Review between April 20-24, 2026 at NIH Rockledge II facility in Bethesda, Maryland to review and evaluate grant applications
Close all meetings to the public in accordance with 5 U.S.C. 552b(c)(4) and (c)(6) to protect confidential trade secrets, commercial property, patentable material, and personal information
Designate a specific Scientific Review Officer as contact person for each of the 13 meetings with verified contact information including phone number and email address
Maintain grant applications and meeting discussions as confidential, preventing disclosure of trade secrets, commercial property, or personal information of applicants
Conduct meetings in virtual format only, as specified for each of the 13 panels scheduled in April 2026